16 March 2018 EMA/CVMP/141912/2018 Committee for Medicinal Products for Veterinary Use
MRL summary opinion 1
Isoflurane Porcine species
On 15 March 2018, the Committee for Medicinal Products for Veterinary Use (CVMP) adopted an opinion 2 recommending the establishment of MRLs for isoflurane in porcine species and amending the existing entry for Equidae with regard to the ‘Other provisions’ in Table 1 (Allowed substances) of the Annex to Commission Regulation (EU) No 37/2010 of 22 December 2009, in accordance with the following table: Pharmaco
Marker
Animal
-logically
residue
species
NOT
Equidae
Target
Other
Therapeutic
tissues
provisions
classification
No MRL
NOT
For use by
General
required
APPLICABLE
inhalation
anaesthetics
No MRL
NOT
For use by
required
APPLICABLE
inhalation in
MRLs
active substance Isoflurane
APPLICABLE Porcine
piglets up to 7 days of age.
1
Summaries of opinion are published without prejudice to the Commission Decision. Applicants may request re-examination of any CVMP opinion, provided they notify the European Medicines Agency in writing of their intention to request such re-examination within 15 days of receipt of the opinion 2
30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact
Isoflurane summary opinion - European Medicines Agency - Europa EU
Mar 15, 2018 - 30 Churchill Place â Canary Wharf â London E14 5EU â United Kingdom. An agency of the European Union ... Animal species. MRLs. Target tissues. Other provisions. Therapeutic classification. Isoflurane. NOT. APPLICABLE. Equidae. No MRL required. NOT. APPLICABLE. For use by inhalation.